#ghrh

1 article

Approach: Data as art, with a conceptual twist. Palette: bold color field (D).

Subject: a single glass syringe lying on a saturated mustard-yellow acrylic surface, shot from a low three-quarter angle with a shallow depth of field. Behind it, a long arc of thin copper wire rises in a gentle curve from a small spike to a broad plateau and then slowly tapers, echoing a hormone curve stretched across days. Small, evenly spaced glass beads sit along the wire, each slightly larger toward the plateau. One bead glows soft electric green.

Lighting: hard single softbox from the upper left, creating crisp, short shadows in warm umber on the yellow. Specular highlights on the glass and copper.

Mood: precise, patient, and quietly analytical, with a slow-release rhythm. No text or markings anywhere.

CJC‑1295 kliničko ispitivanje na ljudima: šta originalni podaci o GH i IGF‑I pokazuju

BY HELIX WARD · 19. окт 2026.

Jedna injekcija CJC‑1295 podigla je nivo hormona rasta (GH) 2‑do 10‑puta tokom šest dana ili duže, a IGF‑I 1,5‑do 3‑puta tokom 9‑11 dana kod zdravih odraslih osoba starosti od 21 do 61 godine. Poluživot peptida procenjen je na 5,8‑8,1 dana, a IGF‑I je ostao iznad bazalne vrednosti najduže 28 dana nakon ponovljenog doziranja. Nisu zabeležene ozbiljne neželjene reakcije, a doze od 30‑60 µg/kg su se najbolje podnosile. Ispitivanje iz 2006. godine merilo je samo hormone i sigurnost, ne i promene mišićne mase, masnog tkiva ili sportskih performansi. U nastavku je prikazano šta originalni podaci zaista pokazuju, kako se CJC‑1295 s DAC‑om razlikuje od mod GRF 1‑29 i zašto je ovaj peptid i dalje neodobren i zabranjen od strane WADA‑e.